Skip to content

A study to evaluate the Moisturization Properties of Test Products in Healthy Adult Human Participants

A Single Center, Application Site Randomized, Blinded, Moisturization Study to Evaluate the Moisturization Properties of Test Products in Healthy Adult Human Participants. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111348
Enrollment
36
Registered
2026-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Face & Body Lotion: Approx. 50 mg, Neat, Single application on volar forearms Intervention2: Face & Body Cream: Approx. 50 mg, Neat, Single application on volar forearms Intervention3

Sponsors

NMantra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy males and non-pregnant/non-lactating females (Preferably equal ratio) with age 18 to 50 years (both inclusive at the time of consent). 2. Participants having good general health as determined by the Investigator on the basis of medical history. 3. Female participants of childbearing potential must have a negative urine pregnancy test performed at enrollment visit. 4. Participants who are willing to abstain from using any cosmetic product on test sites during the course of the study. 5. Participants who are willing to participate in the study and give signed consent. 6. Participants should be willing and able to follow the study protocol to participate in the study Participants with intact, healthy skin at the designated test sites, free from cuts, abrasions, active dermatoses, or dermatological conditions. 7. Participants willing to follow all the acceptable forms of contraception as applicable.

Exclusion criteria

Exclusion criteria: 1. Participants using Body milk /lotion / cream, cosmetics or any other body moisturizing product 3-5 days prior to study. 2. Participants who are on systemic medication or any medications would compromise the study. 3. Chronic illness which may influence the cutaneous state. 4. Participants having a history of diabetes. 5. Participants with known allergy or sensitivity to cosmetic products and/or any ingredients of the test product. 6. Participants with medical history (past/present) of significant dermatological diseases or conditions, such as atopy, psoriasis, vitiligo or other conditions known to alter skin appearance or physiologic response (e.g., porphyria) chronic urticaria, or sunburn, rashes. 7. Participant having skin irritation, blemishes, excessive hair, moles, pigmentation, pimples, marks (e.g., tattoos, scars, and sunburn), open wounds, cuts, abrasions, irritation symptoms or any dermatological condition on the test site(s) i.e., volar forearm that can interfere with the reading. 8. Participants participating in a similar clinical study, currently or within the last four weeks. 9. Any participants, in the Investigator opinion not considered suitable for enrollment. 10. Any other condition which could warrant exclusion from the study, as per the Dermatologist s/investigator s discretion.

Design outcomes

Primary

MeasureTime frame
Instrumental and Dermatological AssessmentTimepoint: Day 01 [(Before application (i.e., baseline) and after application at 01 hour (plus 15 mins), 04 hours (plus 15 mins) and 6 hours (plus 15 mins)] and on Day 02 [24 hours (plus 15 mins) after application].

Secondary

MeasureTime frame
Subjective EvaluationTimepoint: Day 02 [24 hours plus 15 mins) after application].

Countries

India

Contacts

Public ContactDr Parth Joshi

Cliantha Research

ssethi@cliantha.com9825784942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026